Synchronous Bilateral Breast Carcinoma
2 clinical trials · Condition
◉ Watch Synchronous Bilateral Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial (NCT04457596) | Alliance for Clinical Trials in Oncology | 2021-03-02 |
| Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer (NCT01272037) | National Cancer Institute (NCI) | 2011-02-28 |
Track Synchronous Bilateral Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.